-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Maintains Buy on Repligen, Lowers Price Target to $150

Benzinga·06/03/2026 17:47:48
Listen to the news
HSBC analyst Sidharth Sahoo maintains Repligen (NASDAQ:RGEN) with a Buy and lowers the price target from $170 to $150.